biotechnology

In searching for a cure to the enduring enigma of the coronavirus pandemic, one small biotechnology company is on a mission to develop a new, possibly the world’s first-ever, drug specifically geared to treat long COVID patients. NBC New York’s Linda Gaudino reports.

However, Biden said the U.S. currently has enough vaccine supply to ensure people ages 50 and older can get their fourth doses.

President Joe Biden will give an update on the U.S. fight against Covid-19 and receive his second vaccine booster shot.

Dr. Peter Marks said the U.S. might need to switch to a different vaccine that targets specific variants of Covid.

The more contagious omicron subvariant, BA.2, is now the dominant version of Covid in the U.S., at nearly 55% of sequenced Covid cases, according to the CDC.

The CDC and FDA made the decision without consulting their committees of independent vaccine experts.

“You have people that are younger adults that have comorbidity factors, and they might need [a] sooner fourth dose to protect them,” CEO Stephane Bancel told CNBC.

Data from Walgreens, which conducts testing at its pharmacies nationwide, shows BA.2 as the dominant variant at 51% of all positive Covid cases as of March 19.

Moderna also asked the FDA to authorize its vaccine for children 6- to 11-years-old, the company announced Wednesday.

Pfizer expects to start supplying the antiviral pills, Paxlovid, to UNICEF beginning next month and will continue to do so through the end of the year.

An FDA advisory committee will discuss Covid-19 boosters for the coming months and what factors would make it necessary to update the shots to target specific variants.

Investors see growth opportunity in Femtech as more employers adopt coverage for women’s health services and technology

Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021, a 15% increase over the prior year.

Merck plans to submit the data on early stage lung cancer to the FDA as soon as possible.

Jha leads Brown University’s School of Public Health and previously headed Harvard’s Global Health Institute.

Moderna CEO Stephane Bancel has sold more than 2.8 million shares since January 2020 at a total value of more than $408 million.

The White House is urging Congress to pass $22.5 billion in Covid spending, warning the U.S. is running out of money to fight the virus.

The meeting would serve as a high-level show of force for NATO countries, which have forged a stronger bond in response to Russia’s unprovoked attack.

Shares of Moderna, BioNTech, Pfizer, Johnson & Johnson and Novavax rose on Monday as China battles its worst Covid outbreak in two years.

Nathan Chen’s sister Janice co-founded Mammoth Biosciences while watching her brother skate in the Olympics. Her plan: get the CRISPR start-up to $100 billion.